The enigma of Ebola virus persistence has taken a step closer to being unraveled thanks to a groundbreaking study utilizing cerebral organoid models. This research, conducted by a collaborative team from the Icahn School of Medicine at Mount Sinai and the Bernhard Nocht Institute for Tropical Medicine (BNITM), among others, has unveiled intriguing insights into how Ebola virus manages to linger in the human body, potentially leading to relapses and new outbreaks.
The Stealthy Nature of Ebola Virus
Ebola virus, a formidable filovirus, has the ability to remain undetected within the human body for extended periods, often hiding in immune-privileged areas like the central nervous system. This stealthy behavior poses a significant threat, as it can trigger a resurgence of Ebola virus disease or even spark fresh outbreaks. The recent findings, published in Nature Microbiology, offer a glimmer of hope in our understanding of this elusive virus.
Cerebral Organoids: A Window into Ebola Persistence
The mechanisms behind Ebola virus' long-term survival have been shrouded in mystery. Does it persist in specific tissues or individual cells? Does it manipulate its genetic code to evade our immune system's detection? Due to the complexities of researching the human central nervous system, suitable model systems are essential. Enter the cerebral organoid model, a powerful tool that has enabled researchers to delve into the intricate world of Ebola virus persistence.
Unraveling the Mystery with Cerebral Organoids
Lina Widerspick, PhD, the first author of the publication and a former researcher at BNITM, explains the significance of these cerebral organoids. "They allow us to investigate the precise mechanisms employed by Ebola virus and other filoviruses to persist in the human central nervous system. Through experiments in this model system, we gain insights that enhance our understanding of the long-term consequences of persistence, such as the severe and sometimes fatal inflammation observed in Ebola virus disease survivors with meningoencephalitis."
One of the key advantages of organoids is the ability to study these phenomena in a human context rather than relying solely on animal models. This not only aids in reassessing and optimizing treatments like antivirals but also opens up avenues to reduce the reliance on animal models in infectious disease research, a significant ethical consideration.
Ebola's Longevity in Cerebral Organoids
The researchers demonstrated that Ebola virus, along with other filoviruses like Sudan, Reston, and Marburg virus, can replicate in cerebral organoids for an impressive 120 days. Furthermore, they discovered that Ebola virus infects various cell types within the cerebral organoids, including neurons and astrocytes. Even the brain's immune cells, microglia, were not spared, becoming infected by the virus.
Ebola virus demonstrated its versatility by spreading in two distinct ways within the cerebral organoids: direct transmission from an infected cell to a neighboring cell and by budding from the host cell, the classical method of viral spread. This "productive persistence" indicates that Ebola virus is not merely present in an inactive state within cells but remains infectious, a concerning revelation.
Inflammatory Response and Localized Inflammation
The cerebral organoids produced pro-inflammatory cytokines, yet the immune response was unable to effectively eliminate the virus during the persistent infection. César Muñoz-Fontela, PhD, head of the Virus Immunology research group at BNITM and co-last author of the study, highlights the significance of this finding: "We observed elevated immune and inflammatory responses in the late stages of cerebral organoid culture. This leads us to conclude that a persistent Ebola virus infection in immune-privileged tissues can result in local inflammation. This observation aligns with the fact that some Ebola virus disease survivors develop inflammation of the eye, meninges, or brain months after infection with Ebola virus."
Ebola's Adaptations for Survival
Defective viral genomes are a well-known strategy employed by many viruses to suppress their replication, allowing them to survive in the body in a weakened but long-lasting form. It is also understood that Ebola virus genomes mutate during long replication periods due to their genetic machinery's inability to proofread genomes as human machinery does. The research team identified defective viral genomes and particles, as well as mutations in the Ebola virus genomes, in late-stage persistently infected cerebral organoids.
Gustavo Palacios, PhD, Professor of Microbiology at the Icahn School of Medicine, co-last author of the publication, and an expert on Ebola virus genomics, explains: "Many of these mutations have been proposed to reduce or prevent viral replication in naturally occurring infections. The fact that Ebola virus behaves similarly in this model system as it does in human infections underscores the suitability of our cerebral organoids for investigating filovirus persistence."
The researchers also identified mutations that have not been previously described in Ebola virus disease survivors. Further investigations are warranted to determine if these mutations are causally linked to filovirus persistence.
Looking Ahead: The Potential of Cerebral Organoids
"Our work in human cerebral organoids highlights the potential of this model system to investigate persistent infections in immune-privileged tissues," said Dr. Palacios. "Further studies are now crucial to delve deeper into the long-term interactions between virus and host, expanding our research to less-studied filoviruses like Reston, Taï Forest, Bombali, and Bundibugyo virus, and enhancing our understanding of filoviral persistence mechanisms."
This research not only advances our understanding of Ebola virus persistence but also opens up new avenues for exploring the complex interactions between viruses and their hosts, offering hope for improved treatments and a deeper comprehension of these elusive pathogens.
